Specific Triacylglycerols Accumulate via Increased Lipogenesis During 5-FU-Induced Apoptosis

Nasi Li1, Darleny Y Lizardo1, G Ekin Atilla-Gokcumen1

  • 1Department of Chemistry, University at Buffalo, The State University of New York (SUNY) , Buffalo, New York 14260, United States.

ACS Chemical Biology
|July 19, 2016
PubMed

Insights

Specific triacylglycerols accumulate during apoptosis, driven by biosynthesis. This molecular regulation may prevent lipid oxidation following p53 activation.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Lipidomics

Background:

  • Lipids regulate essential cellular functions like survival, division, and death.
  • Apoptosis, or programmed cell death, involves significant membrane changes.
  • The precise roles of specific lipids during apoptosis remain unclear.

Purpose of the Study:

  • To investigate the molecular regulation of triacylglycerols during 5-fluorouracil-induced apoptosis in HCT-116 cells.
  • To identify specific triacylglycerol species that change during apoptosis.
  • To elucidate the enzymatic pathways involved in triacylglycerol metabolism during this process.

Main Methods:

  • Global lipid profiling using mass spectrometry.
  • Analysis of enzyme expression and activity involved in triacylglycerol biosynthesis and metabolism.
  • Cellular apoptosis induction using 5-fluorouracil.

Main Results:

  • Specific triacylglycerols were found to accumulate during 5-fluorouracil-induced apoptosis.
  • Evidence suggests that triacylglycerol biosynthesis is responsible for these accumulations.
  • These changes occur downstream of p53 activation.

Conclusions:

  • Triacylglycerols are regulated at a molecular level during apoptosis.
  • Triacylglycerol accumulation may serve to prevent lipid oxidation.
  • This highlights a novel role for lipids in the apoptotic process.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
63
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
5.5K
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
1.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K